Incepto

About

Incepto operates a curated platform that selects, co-develops and deploys subscription-based AI applications for medical imaging, integrating into hospital workflows and requiring no new equipment.

Mission

Incepto is a French digital-health platform that offers doctors and hospitals a portfolio of AI solutions for medical imaging designed to improve diagnostic quality and save clinical time without requiring new equipment. Founded in 2018, the company positions itself as the first European platform for AI applied to medical imaging and reports about a hundred clinics equipped and more than 100,000 patients monitored each month. Its core product is a curated platform that selects and deploys high-quality AI applications and co-develops new tools with clinicians—examples include ARVA (aortic aneurysm CT) and KEROS (knee MRI). Incepto announced five new partnerships (IB Lab, Milvue, PAIRE, SmartSoft and Thirona) to expand applications across emergency care, oncology, orthopaedics, rheumatology and pneumology. To scale in Europe it is launching offers and creating subsidiaries in Germany, Spain, Italy and Portugal, and aims to treat one million European patients per month by 2024. The company raised €27 million to support this European development and to continue selecting, co-creating and deploying AI solutions while supporting transformation of clinical workflows. Incepto, established in 2018 and based in Paris, developed a platform that distributes AI applications for medical imaging. Physicians and hospitals can access the platform's tools via subscription and require no special equipment. Ten medical centers and clinics have already subscribed to the service. The company targets 35 subscribers by the end of 2020. Incepto has raised €5.6 million from several investors, including AXA Venture Partners, according to the article. The business model centers on subscription access to diagnostic imaging apps for clinical users.

Quick Facts